Since CK19 was considered a marker of hepatic progenitor cells and biliary epithelial cells, the subset of HCC expressing CK19 in metastatic LN may represent an HCC category that originates from HPC or by metaplasia and carries an extremely poor prognosis. The gene discussed is KRT19; the disease is hepatocellular carcinoma.